BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 21703876)

  • 1. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study.
    Béjot Y; Osseby GV; Gremeaux V; Durier J; Rouaud O; Moreau T; Giroud M
    J Neurol Sci; 2009 Dec; 287(1-2):84-8. PubMed ID: 19766250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly.
    Kaplan RC; Tirschwell DL; Longstreth WT; Manolio TA; Heckbert SR; Lefkowitz D; El-Saed A; Psaty BM
    Neurology; 2005 Sep; 65(6):835-42. PubMed ID: 16186519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
    Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
    Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.
    Padma V; Fisher M; Moonis M
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):867-76. PubMed ID: 15500432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the quality of secondary ischemic stroke prevention in selected urban areas of Poland and Ukraine: the ASCEP study results.
    Chwojnicki K; Yagensky A; Wierucki L; Sichkaruk I; Sydor N; Nyka WM; Wyrzykowski B; Zdrojewski T
    Eur Neurol; 2011; 65(6):323-31. PubMed ID: 21576969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia.
    El-Mitwalli A; Azzam H; Abu-Hegazy M; Gomaa M; Wasel Y
    Clin Neurol Neurosurg; 2013 Jul; 115(7):944-7. PubMed ID: 23069275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
    Po HL; Lin YJ; Hseuh IH
    Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
    Uchiyama S; Ishizuka N; Shimada K; Teramoto T; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Minematsu K; Matsumoto M; Ikeda Y;
    Stroke; 2016 Jun; 47(6):1605-11. PubMed ID: 27165949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
    Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL
    Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin non-responder in Thai ischemic stroke patients.
    Suanprasert N; Yadee T; Mahasirimongkol S; Jongjaroenprasert W; Tantirithisak T
    J Med Assoc Thai; 2013 May; 96(5):523-30. PubMed ID: 23745305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin resistant patients with recent ischemic stroke.
    Castilla-Guerra L; Navas-Alcántara MS; Fernández-Moreno MC
    Rev Clin Esp (Barc); 2014 Apr; 214(3):145-9. PubMed ID: 24211052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.